APRE
Aprea Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD0.65
-0.02 (-2.54%)
Rating:B-
Company Profile
CEO
Oren Gilad
IPO Date
2019-10-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$0.68
Prev. Close
$0.67
Day Low
$0.65
Day High
$0.68
52W Low
$0.55
52W High
$2.22
Market Cap
$0.00B
Volume
0.04M